Akiko Morimoto l Data Analysis | Research Excellence Award

Published on by Research Data Analysis

Prof. Akiko Morimoto l Data Analysis | Research Excellence Award

Osaka Metropolitan University | Japan

Prof. Akiko Morimoto is a senior academic leader and researcher in nursing informatics with a doctoral background in health sciences and extensive experience in higher education and research governance. She holds a Ph.D. in Health Sciences and has progressed through lecturer, associate professor, and professor roles, alongside senior university leadership responsibilities. Her research interests center on nursing informatics, nursing data science, evidence-based practice, cardiovascular epidemiology, and health communication. Her research skills include epidemiological analysis, health data analytics, evidence synthesis, program evaluation, and scholarly publishing, with multiple awards and national committee roles underscoring her sustained contributions to nursing science, education innovation, and evidence-based healthcare advancement.

Citation Metrics (Scopus)

1400
1000
600
200
0

Citations
181

Documents
7

h-index
3

Citations

Documents

h-index


View Scopus Profile

Featured Publications

Associations of Total Daily Working Hours Encompassing Unpaid Care and Domestic Work with Nonrestorative Sleep and Mental Health

– Social Science & Medicine, 2026
Social Determinants of Health Associated with Underweight among Middle-Aged Japanese Men and Women

– Frontiers of Nursing, 2025 (in press)
Current State of the Experience of Receiving Evidence-Based Practice Education

– NSC Nursing, 4(4), 64–104, 2025
Development and Evaluation of a Clinical Scenario‐Based Education Program

– Japan Journal of Nursing Science, 22(4), 2025
Risk for Physical Inactivity Due to Inadequate Health Literacy

– Frontiers of Nursing, 2025

Haleh Ayatollahi | Public Health Informatics | Research Excellence Award

Published on by Research Data Analysis

Dr. Haleh Ayatollahi | Public Health Informatics | Research Excellence Award

Iran University of Medical Sciences | Iran

Haleh Ayatollahi is a Professor of Medical Informatics with extensive experience in health information management, digital health, and health technology assessment. She holds a PhD in Health Informatics from the University of Sheffield (UK), an MSc and BSc in Medical Records from Iran University of Medical Sciences, and an associate degree in the same field. She has held several senior academic and executive roles, including Director of the Deputy of Research and Technology at both the School of Health Management and Information Sciences and the Health Management and Economics Research Centre, and membership on the Medical Informatics Evaluation and Examination Board. Her academic career spans teaching, research leadership, postgraduate administration, and international collaboration. Her research focuses on telemedicine, mobile health, clinical decision support systems, artificial intelligence in healthcare, digital health evaluation, health information systems, patient safety, and technology adoption, with strong contributions to policy briefs and global health studies, including the Global Burden of Disease projects. She has authored 108 peer-reviewed documents with 6,293 citations across 5,499 citing documents and an h-index of 21, reflecting sustained scholarly impact. She has contributed to high-impact journals such as The Lancet, BMC series, Digital Health, and PLOS ONE, and has received multiple academic and research recognitions for excellence in education, research productivity, and leadership in medical informatics.

View Scopus Profile View Google Scholar

Featured Publications


Clinicians’ Knowledge and Perception of Telemedicine Technology

– Perspectives in Health Information Management, 2015

Hillary Andrews | Data Analysis | Best Researcher Award

Published on by Research Data Analysis

Dr. Hillary Andrews | Data Analysis | Best Researcher Award

Friends of Cancers Research | United States

Dr. Hillary S. Andrews, PhD, is a project leader and policy researcher whose scholarly output reflects strong engagement in cancer research regulation, patient-advocacy partnerships, and translational biomarker work. According to Google Scholar, she has an h-index of 7, with about 395 citations across her publications. She earned her PhD in Endocrinology and Animal Biosciences (Rutgers University, 2016), followed by a T32 NRSA postdoctoral fellowship in Tumor Biology at Georgetown University’s Lombardi Comprehensive Cancer Center. In her professional experience, she has held roles at Avalere Health (Consultant / FDA Fellow), then at Friends of Cancer Research, where she is now Director of Regulatory & Research Partnerships (since Dec 2022), after serving as Science Policy Analyst. Her work includes leading research partnerships like ctMoniTR and the HRD Harmonization Project, developing policy, authoring white-papers and peer-reviewed articles, and presenting findings at international meetings. Her research interests center on regulatory policy in oncology, translational biomarkers (e.g. HRD, circulating tumor DNA), patient access, market access pathways, and partnerships between patient advocates and researchers. Among her recognitions is authorship in high-visibility policy reports and scientific collaborations that bridge stakeholders (e.g. regulators, academia, patient advocates). In conclusion, her career demonstrates a consistent track record of integrating research, regulation, and stakeholder engagement to accelerate patient-centered cancer research and policy.

Profiles : Orcid | Google Scholar

Featured Publications

“Analysis of 20 Independently Performed Assays to Measure Homologous Recombination Deficiency (HRD) in Ovarian Cancer: Findings From the Friends’ HRD Harmonization Project”

“Advancing Evidence Generation for Circulating Tumor DNA: Lessons Learned from A Multi-Assay Study of Baseline Circulating Tumor DNA Levels across Cancer Types and Stages”

“An Analysis of Dosing-Related Postmarketing Requirements for Novel Oncology Drugs Approved by the U.S. Food and Drug Administration, 2012–2022”

“Unraveling Vulnerabilities in Endocrine Therapy-Resistant HER2+/ER+ Breast Cancer”

“Sponsor Perspectives on the Impact of the COVID-19 Pandemic on Interventional Cancer Clinical Trial Protocols and Data Quality”

Asri Wulandari – Genomic Data Analytics – Best Researcher Award 

Published on by Research Data Analysis

Mrs. Asri Wulandari - Genomic Data Analytics - Best Researcher Award 

Padjadjaran University - Indonesia

Author Profile

Early Academic Pursuits

Mrs. Asri Peni Wulandari, M.Sc., Ph.D., was born on August 13, 1965, in Bandung. Her academic journey began at the Institut Teknologi Bandung (ITB), where she earned her Bachelor of Science degree in Biology with a specialization in Microbiology in 1989. Driven by a passion for the life sciences and biotechnology, she pursued her Master's degree at the prestigious Tokyo Institute of Technology in Japan, graduating in 1998 with a focus on Bioscience and Biotechnology. Dr. Wulandari further advanced her expertise by obtaining a Ph.D. in Biotechnology from The University of Tokyo in 2003, cementing her foundation in the field of biosciences.

Professional Endeavors

Mrs. Wulandari's professional career is deeply rooted in academia and research. She is a distinguished professor at Universitas Padjadjaran (UNPAD), where she leads the Department of Biology within the Faculty of Mathematics and Natural Sciences (FMIPA). Her research interests span a broad range of topics within biology, including microbiology, biotechnology, and bioprospecting. Over the past five years, Dr. Wulandari has spearheaded numerous research projects, often focusing on the sustainable utilization of rami (Boehmeria nivea), a plant with significant industrial and medicinal potential.

Contributions and Research Focus

Mrs. Wulandari's research contributions are extensive and impactful. She has led various projects funded by prominent national bodies such as BRIN (Badan Riset dan Inovasi Nasional) and the Ministry of Education, Culture, Research, and Technology (KemendikbudRistekdikti). Her recent projects include:

  • Peningkatan Skala Produksi Serat dan Produk Turunan dari Biomassa Rami (2022-2024): This project aims to enhance the production scale of rami fiber and its derivatives, emphasizing sustainable agricultural practices and industrial applications.
  • Pencarian Kandidat Obat Baru Berbasis Metabolomik dari Rami dengan Pendekatan Machine Learning (2023): This innovative project explores new drug candidates derived from rami using metabolomics and machine learning techniques.
  • Mikrobioma dan Metabolomik Silase Daun Rami dengan Penambahan Probiotik (2023): Investigating the microbiome and metabolomics of rami silage with probiotic additives, this research focuses on improving feed quality and storage stability.

Mrs. Wulandari's work on rami has also led to advancements in biodegradable packaging materials, fire-resistant textiles, and ballistic protection materials, showcasing her dedication to creating practical and environmentally friendly solutions.

Accolades and Recognition

Throughout her illustrious career, Mrs. Wulandari has received numerous accolades for her contributions to science and technology. Her publications in high-impact journals, such as "Toxins," "Materials," and "Applied Food Biotechnology," reflect her commitment to advancing scientific knowledge. Her research on the cytotoxic activity of fungal steroids, tensile strength improvements of rami fiber, and the bioactive compounds of endophytic fungi are particularly notable.

Impact and Influence

Mrs. Wulandari's influence extends beyond her research. As a mentor and leader, she has played a pivotal role in developing academic programs, such as the curriculum for the Merdeka Belajar-Kampus Merdeka (MBKM) initiative at UNPAD. Her efforts in standardizing and enhancing educational frameworks have significantly impacted the quality of biological sciences education in Indonesia.

Her collaborative approach, often involving interdisciplinary teams and partnerships with other institutions, has fostered a robust research environment at UNPAD. Dr. Wulandari's leadership in projects funded by national and international bodies underscores her ability to attract and manage significant research investments.

Legacy and Future Contributions

Looking forward, Mrs. Wulandari aims to continue her pioneering work in biotechnology and sustainable materials. Her ongoing projects, including the development of biodegradable composites and the exploration of rami's medicinal properties, promise to yield innovative solutions to global challenges. Her dedication to mentoring the next generation of scientists ensures that her legacy will endure, inspiring future research and innovation in biological sciences.

In conclusion, Mrs. Asri Peni Wulandari, M.Sc., Ph.D., stands as a beacon of excellence in the field of biology and biotechnology. Her academic and professional journey, marked by significant research contributions and impactful leadership, has left an indelible mark on scientific research and education. As she continues to push the boundaries of knowledge, her work promises to shape the future of sustainable technology and bioprospecting, reinforcing her status as a leading figure in her field.

Notable Publication